Neuragenex Secures $2.6 Billion for Expansion of Opioid Alternative Pain Treatment Centers

Neuragenex Treatment Centers has entered into agreements with ASC Medical Group (ASC) and American Development Partners^® (APD) for construction, marketing and operating capital advancement, and leasing of up to 750 treatment centers over the next 5 years.